Will CRISPR fears fade with familiarity?
By Patricia Stapleton,
The Conversation
| 08. 21. 2017
The first “test-tube baby” made headlines around the world in 1978, setting off intense debate on the ethics of researching human embryos and reproductive technologies. Every breakthrough since then has raised the same questions about “designer babies” and “playing God” – but public response has grown more subdued rather than more engaged as assisted reproductive technologies have become increasingly sophisticated and powerful.
As the science has advanced, doctors are able to perform more complex procedures with better-than-ever success rates. This progress has made in vitro fertilization and associated assisted reproductive technologies relatively commonplace. Over one million babies have been born in the U.S. using IVF since 1985.
And Americans’ acceptance of these technologies has evolved alongside their increased usage, as we’ve gotten used to the idea of physicians manipulating embryos.
But the ethical challenges posed by these procedures remain – and in fact are increasing along with our capabilities. While still a long way from clinical use, the recent news that scientists in Oregon had successfully edited genes in a human embryo brings us...
Related Articles
By Keith Casebonne and Jodi Beckstine [with CGS' Katie Hasson], Disability Deep Dive | 07.24.2025
In this episode of Disability Deep Dive, hosts Keith and Jodi explore the complex interplay between disability science, technology, and ethics with guest Katie Hasson, Associate Director at the Center for Genetics and Society. The conversation delves into...
By Rob Stein, NPR | 07.16.2025
Scientists can protect children from being born with certain devastating genetic disorders by creating "three-parent" babies, according to the results of a landmark study released Wednesday.
British researchers used the experimental technique to help families have eight children who appear...
By Jared Whitlock, Endpoints News | 07.15.2025
Patient groups face a harder and unpredictable path going state-by-state to boost screening for rare but treatable conditions after the Trump administration disbanded a federal advisory committee on newborn screening.
In April, the Advisory Committee on Heritable Disorders in Newborns...
By Charlie Warzel and Hana Kiros, The Atlantic | 06.24.2025
Image "Elon Musk" by Debbie Rowe on Wikimedia Commons licensed under CC by S.A. 3.0
In April, Ezibon Khamis was dispatched to Akobo, South Sudan, to document the horrors as humanitarian services collapsed in the middle of a cholera outbreak. As...